160 related articles for article (PubMed ID: 10594840)
1. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation.
Kato N; Endo Y; Tamura G; Katayama Y; Motoyama T
Pathol Int; 1999 Nov; 49(11):947-55. PubMed ID: 10594840
[TBL] [Abstract][Full Text] [Related]
2. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
3. [Pathology of mammary mucinous carcinoma and its molecular markers].
Zhang W; Niu Y; Zhang TX; Liu S; Liu F
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):777-9. PubMed ID: 24447562
[No Abstract] [Full Text] [Related]
4. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
[TBL] [Abstract][Full Text] [Related]
6. Mucinous breast carcinoma and mixed mucinous-infiltrating ductal carcinoma: a comparative cytologic study.
Stanley MW; Tani EM; Skoog L
Diagn Cytopathol; 1989; 5(2):134-8. PubMed ID: 2550188
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
8. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
9. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
10. Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?
Erhan Y; Ciris M; Zekioglu O; Erhan Y; Kapkac M; Makay O; Ozdemir N
Acta Chir Belg; 2009; 109(2):204-8. PubMed ID: 19499682
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
[TBL] [Abstract][Full Text] [Related]
12. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
Kryvenko ON; Chitale DA; Yoon J; Arias-Stella J; Meier FA; Lee MW
Am J Surg Pathol; 2013 Jul; 37(7):1076-84. PubMed ID: 23759933
[TBL] [Abstract][Full Text] [Related]
13. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
[TBL] [Abstract][Full Text] [Related]
14. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Sakamoto DG; Takeshima Y; Inai K
Breast Cancer; 2006; 13(1):58-63. PubMed ID: 16518063
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
[TBL] [Abstract][Full Text] [Related]
16. [Neuroendocrine differentiation and Wilms' tumor protein-1 expression in breast mucinous carcinoma and their significance].
Wang J; Weng S; Jin X; Yu W; Zhou T; Gan M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):45-50. PubMed ID: 27045240
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53, DCC, and HER-2/neu in mucinous carcinoma of the breast.
Hsu YH; Shaw CK
Kaohsiung J Med Sci; 2005 May; 21(5):197-202. PubMed ID: 15960065
[TBL] [Abstract][Full Text] [Related]
18. Mucinous lesions of the breast. A pathological continuum.
Weaver MG; Abdul-Karim FW; al-Kaisi N
Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
[TBL] [Abstract][Full Text] [Related]
19. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
Kim D; Jung WH; Koo JS
Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
